From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. […]
Exactech (NSDQ:EXAC) said it sold off its spine business yesterday to ChoiceSpine for an undisclosed amount and plans to restructure its biologics business. “For nearly a decade, Exactech has driven innovations in spinal surgery and we are pleased to have made meaningful contributions to patient care. We are confident the transfer of these products to ChoiceSpine will […]
Exactech (NSDQ:EXAC) said today it won FDA 510(k) clearance for its Vantage total ankle designed to treat patients with arthritis in the ankle. The Vantage total ankle is designed for total ankle arthroplasty, with a curved surface talar component and curved talus and anatomic tibia designs, the Gainesville, Fla.-based company said. The device incorporates a press-fit […]
Exactech (NSDQ:EXAC) said today it sold the entirety of its dental biologics business to Salvin Dental Specialties, through its Salvin Regenerative subsidiary. Financial terms and other details of the deal were not disclosed. Salvin Dental develops, manufactures and markets implant dentistry regenerative biomaterials and surgical instrumentation, Exactech said. “While it has been a pleasure to […]
The spinal med device market appears to be stabilizing with growth in 3 key areas, according to a letter to investors published this week from Leerink Partner’s Richard Newitter, who attended the North American Spine Society’s annual meeting in Chicago last week. Newitter said the meeting was “neutral-to-positive” for firms in the spinal market, and said […]
Exactech (NSDQ:EXAC) said yesterday it launched its Opterak revision knee system and that the system has been successfully implanted in its 1st set of patients. The revision knee system is composed of proprietary net compression molded polyethylene and is indicated for use in skeletally mature patients undergoing surgery for total knee replacements due to osteoarthritis, osteonecrosis, […]
Exactech (NSDQ:EXAC) said yesterday that it won FDA 510(k) clearance for its Optetrak Logic constrained condylar prosthesis for revision knee arthroplasty patients. The knee prosthesis is approved for indications in patients undergoing total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis, post-traumatic degenerative problems and to replace failed knee devices, the Gainesville, Fla-based company said. […]
Z-Medica said it named Stephen Fanning, the former CEO of Solta Medical, to be its new chief executive.
Wallingford, Conn.-based Z-Medica is developing blood clotting technologies it calls QuikClot.
Considered a leader in diabetes research, Zisser will be involved with a variety of clinical research projects and serve as a medical liaison between Insulet and government leaders, the FDA, and healthcare organizations, Bedford, Mass.-based Insulet said.